Percutaneous coronary intervention (PCI) is a non-surgical procedure utilized to treat coronary artery disease. A balloon catheter and coronary stents are used to remove the plaque and treat narrowing of blood vessels. In a PCI procedure, a coronary guidewire is used to direct the balloon catheter to the site of plaque in the coronary artery. A balloon catheter is thereafter inserted into the coronary artery of the heart and inflated at the site of the plaque. Generally, a stent is placed at that site to mitigate the risk of restenosis at the treatment site. Global percutaneous coronary intervention devices market is expected to grow in the forecast period owing to the rise in the incidence of the heart diseases, diabetes, and coronary artery disease. Further, development of advanced technologies for PCI procedures leads to the growth of the market.
This report studies the market for various devices used in PCI procedures and consists of latest analysis of the global percutaneous coronary intervention devices market through extensive primary and secondary research. A comprehensive understanding of the global market is provided in the report based on quantitative and qualitative research. This report aids the market stakeholders to make informed initiatives in the global percutaneous coronary intervention devices market.
For the analysis, the global percutaneous coronary intervention devices market is categorized based on device type, usage areas, and geographical demarcation. On the basis of device type, the global percutaneous coronary intervention devices market is categorized into coronary stents, PTCA catheters, and coronary guidewires. On the basis of usage areas, the global percutaneous coronary intervention devices market is categorized into hospitals, ambulatory surgical centers, and catheterization labs. Analysis of global percutaneous coronary intervention devices market is performed in terms of market size for the period 2016-2026 considering 2017 as the base year and 2018-2026 as forecast period. CAGRS of each aforementioned segment is calculated for the forecast period.
Based on geographical demarcation, the global percutaneous coronary intervention devices market is analyzed by categorizing the market into five major regions as follows:
On the basis of geographical demarcation, the market size of the global percutaneous coronary intervention devices market is presented for the period 2016-2026 and CAGRs are calculated for the forecast period. Further, geographical regions are analyzed by sub-segmenting them in terms of device type, end-user, and constituent countries.
Major qualitative market assessment factors are incorporated in the report including key market insights, market trends and dynamics, product launches and opportunities. Competitive landscape of major players is provided in a graphical format based on market share, product portfolio, and improvement opportunities. This report also constitutes Porter’s five forces model for the proper understanding of the global percutaneous coronary intervention devices market. Major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Biosensors International Group, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical and Terumo Corporation.
For the purpose of this study, global percutaneous coronary intervention devices market is studied by their following device types:
Percutaneous coronary intervention procedure is performed to treat coronary artery disease by removing the plaque from the coronary arteries. Coronary guidewires are used to direct the PTCA catheters to the site of plaque and thereafter catheters are employed for plaque removal. This is followed by stent placement at the site of plaque to prevent restenosis. In terms of market value, PTCA catheters segment leads the global percutaneous coronary intervention devices market for the year 2017 due to increased adoption in PCI procedures over conventional treatment methods; non-invasive and safer approach of PCI mainly contributes to this shift. In addition, technological advancements in the nature and material of stents will make this segment to grow at the fastest CAGR. Greater prices of stents and their incumbent role in prevention of restenosis mainly drive the growth of this segment.
For the purpose of this study, global percutaneous coronary intervention devices market is studied for their application in following usage area:
Percutaneous coronary intervention (PCI) procedures are adopted across the world for the treatment of coronary heart disease. PCI is a minimally invasive procedure and thereby potentially reduces the risk of post-treatment complications and infections. In terms of market value, hospitals lead the global percutaneous coronary intervention devices market for the year 2017 due to the availability of the skilled professionals required for the PCI procedure. Furthermore, availability of favorable reimbursements in hospitals and devices that aid in minimally invasive techniques such as robotic devices favors the prominent position of hospitals segment. However, with the increase in the number of cases for PCI procedures, the population is turning towards the catheterization labs for the treatment due to quick turnaround time.
Based on geographical regions, the global percutaneous coronary intervention devices market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East and Africa.
As per the research, North America dominated the global percutaneous coronary intervention devices market in the year 2017 and is projected retain its lead in the market throughout forecast period. Adoption of PCI procedures, improved healthcare services and high incidence of coronary artery disease in the region contributes to its dominance. The global percutaneous coronary intervention devices market in North America is expected to further grow due to supportive government initiatives and favorable reimbursement policies. According to the CDC, the coronary artery disease is the most common type of heart disease killing over 370,000 individuals annually. Further, Asia Pacific is anticipated to experience fastest market growth during the forecast years. This regional growth is anticipated due to increasing prevalence of heart diseases, and rising healthcare facilities along with awareness of general population towards heart diseases.
The detailed regional classification of the global percutaneous coronary intervention market is as follows:
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Percutaneous Coronary Intervention Devices Market Portraiture
2.1.1. Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2017 (US$ Bn)
2.1.2. Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 (US$ Bn)
2.1.3. Global Percutaneous Coronary Intervention Devices Market, by Geography, 2017 (US$ Bn)
Chapter 3. Percutaneous Coronary Intervention Devices Market: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Value Chain Analysis
3.7. Porter’s Five Forces Model
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Device Type, 2017
4.2. Coronary Stents
4.3. PTCA Catheters
4.4. Coronary Guidewires
Chapter 5. Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
5.1. Overview
5.1.1. Comparative Analysis: Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 Vs 2026 (Value %)
5.2. Hospitals
5.3. Ambulatory Surgical Centers (ASCs)
5.4. Catheterization Labs
Chapter 6. Percutaneous Coronary Intervention Devices Market, by Geography, 2016 – 2026 (US$ Bn)
6.1. Overview
6.2. North America Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.2.1. North America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.2.2. North America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.2.3. North America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.3.1. Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.3.2. Europe Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.3.3. Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.4.1. Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.4.2. Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.4.3. Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.5.1. Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.5.2. Latin America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.5.3. Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.6.1. MEA Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.6.2. MEA Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.6.3. MEA Percutaneous Coronary Intervention Devices Market, by Region, 2016 – 2026 (US$ Bn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Application Portfolio
7.1.4. Key Developments
7.2. B. Braun Melsungen AG
7.3. Biosensors International Group
7.4. Biotronik SE & Co. KG
7.5. Boston Scientific Corporation
7.6. Getinge AB
7.7. Johnson & Johnson
7.8. Medtronic plc
7.9. St. Jude Medical.
7.10. Terumo Corporation
TABLE 1 Global Percutaneous Coronary Intervention Devices Market Portraiture
TABLE 2 Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 3 Global Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 4 Global Percutaneous Coronary Intervention Devices Market, by Geography, 2016 – 2026 (US$ Bn)
TABLE 5 North America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 6 North America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 7 North America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 8 Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 9 Europe Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 10 Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 11 Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 12 Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 13 Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 14 Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 15 Latin America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 16 Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 17 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 18 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 19 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 20 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 B. Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Biosensors International Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Biotronik SE & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Getinge AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Medtronic plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 St. Jude Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 Percutaneous Coronary Intervention: Market Segmentation
FIG. 2 Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2017 (US$ Bn)
FIG. 3 Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 (US$ Bn)
FIG. 4 Global Percutaneous Coronary Intervention Devices Market, by Geography, 2017 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Coronary Stents Market, 2016 – 2026 (US$ Bn)
FIG. 8 Global PTCA Catheters Market, 2016 – 2026 (US$ Bn)
FIG. 9 Global Coronary Guidewires Market, 2016 – 2026 (US$ Bn)
FIG. 10 Global PCI Market in Hospitals, 2016 – 2026 (US$ Bn)
FIG. 11 Global PCI Market in Ambulatory Surgical Centers, 2016 – 2026 (US$ Bn)
FIG. 12 Global PCI Market in Catheterization Labs, 2016 – 2026 (US$ Bn)
FIG. 13 U.S. Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 14 Canada Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 15 U.K. Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 16 Germany Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 17 Rest of Europe Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 18 Japan Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 19 China Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 20 Rest of Asia Pacific Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 21 Brazil Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 22 Mexico Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 23 Rest of Latin America Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 24 GCC Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 25 Rest of Middle East and Africa Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)